Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
zoe.wong@imm.ox.ac.uk

Research groups

Psaila Group: Megakaryocytes, Platelets and Myeloproliferative Neoplasms

Zoë Wong

DPhil Student

Recent publications

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Rampotas A. et al, (2026), Sci Transl Med, 18

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia.

Gui G. et al, (2025), Bone Marrow Transplant, 60, 144 - 153

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia.

Gui G. et al, (2025), Bone Marrow Transplant, 60, 154 - 160

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia.

Hegde PS. et al, (2025), Bone Marrow Transplant, 60, 175 - 177

A proinflammatory stem cell niche drives myelofibrosis through a targetable galectin-1 axis.

Li R. et al, (2024), Sci Transl Med, 16

More publications